Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

manjrilall.com Blueprint · Rev.39

Sheet A · Product board

prohealth bpc-157 500 mcg 60 capsules coa Infiniwell, BPC, Rapid Pro, mcg, Enhance 30ml Bacteriostatic Water for Weight:50mg

Unit price

USD20.67

USD70.67

Pay in 4 interest-free payments of $5.17 Learn more

Field rating

4.8

Verified studio score · Spec revision current

Fit · Size

prohealth bpc-157 500 mcg 60 capsules coa

prohealth bpc-157 500 mcg 60 capsules coa Infiniwell, BPC, Rapid Pro, mcg, Enhance 30ml Bacteriostatic Water for Weight:50mg

SKU: 79545592693

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 24 - Sep 29

Description

prohealth bpc-157 500 mcg 60 capsules coa Infiniwell, BPC, Rapid Pro, mcg, Enhance 30ml Bacteriostatic Water for Weight:50mg

30ml Bacteriostatic Water for Injection (5 Pack)

Stable gastric pentadecapeptide BPC 157, Robert's cytoprotection, and target therapy

Enhance

Weight:50mg

Batch & Purity Information Batch Number: BACWATER Purity / Standard: Sterile solution All products are for research and laboratory use only

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

foxo4-dri dosing protocol foxo4 dri peptide dosage improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI Peptide Guide: Senolytic – FOXO4-DRI: Human Trial Status, Cancer –

US$ 28.47

5.0 (17 reviews)

Frontiers

Frontiers

US$ 26.35

4.6 (15 reviews)

foxo4-dri peptide senolytic study skin regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: The Senolytic Peptide That – foxo4-dri peptide senolytic human trial –

foxo4-dri peptide senolytic study skin regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: The Senolytic Peptide That – foxo4-dri peptide senolytic human trial –

US$ 28.26

4.6 (30 reviews)

foxo4-dri peptide senolytic study regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: Human Trial Status, Cancer –

foxo4-dri peptide senolytic study regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: Human Trial Status, Cancer –

US$ 23.92

5.0 (9 reviews)

FOXO4-DRI Peptide

FOXO4-DRI Peptide

US$ 28.73

4.6 (29 reviews)

FOXO4-DRI UK | Senolytic Peptide Research

FOXO4-DRI UK | Senolytic Peptide Research

US$ 22.15

4.8 (7 reviews)

foxo4-dri senolytic peptide human trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging Frontiers foxo4-dri senolytic peptide human trial –

foxo4-dri senolytic peptide human trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging Frontiers foxo4-dri senolytic peptide human trial –

US$ 21.30

4.3 (14 reviews)

FOXO4-DRI: Human Trial Status, Cancer Research & Senolytic Data

FOXO4-DRI: Human Trial Status, Cancer Research & Senolytic Data

US$ 23.43

4.0 (9 reviews)

Frontiers

Frontiers

US$ 25.12

4.2 (22 reviews)

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

US$ 25.76

4.5 (25 reviews)

FOXO4-DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)

FOXO4-DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)

US$ 20.11

4.4 (18 reviews)

foxo4-dri human trial FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI improves spermatogenesis in aged –

foxo4-dri human trial FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI improves spermatogenesis in aged –

US$ 25.69

4.1 (5 reviews)

foxo4-dri senolytic peptide human trials nct FOXO4-DRI: Trial Status, Cancer Research & Data FOX04-DRI foxo4-dri human trials senolytic peptide –

foxo4-dri senolytic peptide human trials nct FOXO4-DRI: Trial Status, Cancer Research & Data FOX04-DRI foxo4-dri human trials senolytic peptide –

US$ 28.59

4.7 (6 reviews)

foxo4-dri senolytic 2024 human trial foxo4 dri trials FOXO4-DRI: The Peptide That Targets Zombie foxo4-dri senolytic peptide human trial –

foxo4-dri senolytic 2024 human trial foxo4 dri trials FOXO4-DRI: The Peptide That Targets Zombie foxo4-dri senolytic peptide human trial –

US$ 24.12

4.8 (8 reviews)

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

US$ 22.48

4.9 (8 reviews)

foxo4-dri peptide senolytic study human trial regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI 10mg vial Targeted Apoptosis of Senescent Cells –

foxo4-dri peptide senolytic study human trial regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI 10mg vial Targeted Apoptosis of Senescent Cells –

US$ 21.14

4.9 (9 reviews)

Buy FOXO4-DRI (Proxofim)

Buy FOXO4-DRI (Proxofim)

US$ 21.89

4.1 (20 reviews)

foxo4-dri human trial senolytic peptide regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: Status, Cancer – foxo4-dri human clinical trial (10mg) –

foxo4-dri human trial senolytic peptide regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: Status, Cancer – foxo4-dri human clinical trial (10mg) –

US$ 29.02

4.8 (21 reviews)

foxo4-dri cancer senolytic human trial FOXO4-DRI: Status, Research & Data Peptide inhibitors targeting FOXO4-p53 interactions – foxo4-dri senolytic peptide animal study –

foxo4-dri cancer senolytic human trial FOXO4-DRI: Status, Research & Data Peptide inhibitors targeting FOXO4-p53 interactions – foxo4-dri senolytic peptide animal study –

US$ 24.28

4.5 (7 reviews)

FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice

FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice

US$ 25.98

4.8 (26 reviews)